Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideyasu Oh

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Japanese Journal of Ophthalmology|March 10, 2023
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trialMasahiko Shimura, Shigehiko Kitano, Nahoko Ogata, et al.
Retina (Philadelphia, Pa.)|January 19, 2005
Is removal of internal limiting membrane always necessary during stage 3 idiopathic macular hole surgery?Tetsushi Kimura, Masayo Takahashi, Hitoshi Takagi, et al.
Investigative Ophthalmology & Visual Science|May 31, 2002
Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROPNoriko Miyamoto, Michiko Mandai, Hitoshi Takagi, et al.
Japanese Journal of Ophthalmology|June 14, 2002
Role of vitronectin receptor-type integrins and osteopontin in ischemia-induced retinal neovascularizationHitoshi Takagi, Kiyoshi Suzuma, Atsushi Otani, et al.
The British Journal of Ophthalmology|August 6, 2018
Long-term results of photodynamic therapy or ranibizumab for polypoidal choroidal vasculopathy in LAPTOP studyNoriko Miyamoto, Michiko Mandai, Akio Oishi, et al.
Molecular Vision|September 9, 2004
Alterations in expression of angiopoietins and the Tie-2 receptor in the retina of streptozotocin induced diabetic ratsHirokazu Ohashi, Hitoshi Takagi, Shinji Koyama, et al.
Ophthalmology|February 4, 2014
LAPTOP study: a 24-month trial of verteporfin versus ranibizumab for polypoidal choroidal vasculopathyAkio Oishi, Noriko Miyamoto, Michiko Mandai, et al.
The American Journal of Pathology|January 10, 2006
EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdownTomonari Ojima, Hitoshi Takagi, Kiyoshi Suzuma, et al.
Circulation Research|February 14, 2004
Phosphatidylinositol 3-kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activityHirokazu Ohashi, Hitoshi Takagi, Hideyasu Oh, et al.
The American Journal of Pathology|April 28, 2004
Transcription factor Ets-1 mediates ischemia- and vascular endothelial growth factor-dependent retinal neovascularizationDaisuke Watanabe, Hitoshi Takagi, Kiyoshi Suzuma, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Japanese Journal of Ophthalmology|March 10, 2023
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trialMasahiko Shimura, Shigehiko Kitano, Nahoko Ogata, et al.
Retina (Philadelphia, Pa.)|January 19, 2005
Is removal of internal limiting membrane always necessary during stage 3 idiopathic macular hole surgery?Tetsushi Kimura, Masayo Takahashi, Hitoshi Takagi, et al.
Investigative Ophthalmology & Visual Science|May 31, 2002
Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROPNoriko Miyamoto, Michiko Mandai, Hitoshi Takagi, et al.
Japanese Journal of Ophthalmology|June 14, 2002
Role of vitronectin receptor-type integrins and osteopontin in ischemia-induced retinal neovascularizationHitoshi Takagi, Kiyoshi Suzuma, Atsushi Otani, et al.
The British Journal of Ophthalmology|August 6, 2018
Long-term results of photodynamic therapy or ranibizumab for polypoidal choroidal vasculopathy in LAPTOP studyNoriko Miyamoto, Michiko Mandai, Akio Oishi, et al.
Molecular Vision|September 9, 2004
Alterations in expression of angiopoietins and the Tie-2 receptor in the retina of streptozotocin induced diabetic ratsHirokazu Ohashi, Hitoshi Takagi, Shinji Koyama, et al.
Ophthalmology|February 4, 2014
LAPTOP study: a 24-month trial of verteporfin versus ranibizumab for polypoidal choroidal vasculopathyAkio Oishi, Noriko Miyamoto, Michiko Mandai, et al.
The American Journal of Pathology|January 10, 2006
EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdownTomonari Ojima, Hitoshi Takagi, Kiyoshi Suzuma, et al.
Circulation Research|February 14, 2004
Phosphatidylinositol 3-kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activityHirokazu Ohashi, Hitoshi Takagi, Hideyasu Oh, et al.
The American Journal of Pathology|April 28, 2004
Transcription factor Ets-1 mediates ischemia- and vascular endothelial growth factor-dependent retinal neovascularizationDaisuke Watanabe, Hitoshi Takagi, Kiyoshi Suzuma, et al.
Pageof 5